NextCure, Inc. (NXTC)
NASDAQ·Healthcare·Biotechnology
$5.92
+34.55%
Mkt Cap $19.58M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$15.00
Range $15.00 – $15.00
Implied Upside
+153.4%
Consensus $15.00 vs current $5.92
NASDAQ·Healthcare·Biotechnology
$5.92
+34.55%
Mkt Cap $19.58M
No recent rating data.
Price Target (3 analysts)
$15.00
Range $15.00 – $15.00
+153.4%
Consensus $15.00 vs current $5.92